Agenda Clinical Hematology & Oncology 2020

Saturday, February 15, 2020

Topic: Nonmalignant Hematology


7 a.m.   

Registration, Breakfast & View Exhibits


7:50 a.m.            

Welcome and Introduction

Michael Kosty, MD


Moderator: Anuj Mahindra, MD


8 a.m.   

Thrombocytopenia in the Hospitalized Patient & HIT


8:45 a.m.

Complement-Mediated Hematologic Disorders, TMA Disorders


9:30 a.m.            

Break & View Exhibits


10 a.m.

Clinically Useful Treatment Algorithms in Benign Hematology


10:45 a.m.          

Macroglobulinemia


11:30 a.m.          

The Most Important Bleeding Publications in 2019/2020


12:15 p.m.          

Lunch


Moderator: Marin Xavier, MD    


1:15 p.m.

The Most Important Thrombosis Publications in 2019/2020


2 p.m.

Anticoagulation of Critically Ill Patients


2:45 p.m.

Anti-Platelet Theory


3:30 p.m.

Break & View Exhibits


4 p.m.   

Workshops (Concurrent sessions)


Perioperative Thrombocytopenia


Outpatient Conundrums in Hemostasis


Complex Thrombocytopenic Patients Referred to Me


Less Common Thromboses: 2020 Update


5 p.m.   

Adjourn


5:15 p.m.            

Welcome & Networking Reception 

Sunday, February 16, 2020

Topic: Malignant Hematology


7 a.m.   

Breakfast & View Exhibits


Moderator: Alan Saven, MD        


8 a.m.   

State-Of-The-Art AML Therapy, and Incorporation of Novel Anti-AML Targeted Therapies in 2020              


8:45 a.m.

Follicular Lymphoma Update


9:30 a.m.

Break & View Exhibits


10 a.m.

The Impact of Molecular Signature on Prognostication in MPN


10:45 a.m.

Myeloproliferative Disorders - Update


11:30 a.m.

CAR-T Therapy of Lymphoma


12:15 p.m.          

Lunch


Moderator: James Mason, MD


1:15 p.m.

Refining Therapeutic Options for DLBCL


2 p.m.

Immunizations to Prevent Infections in Patients with Hematologic Disorders


2:45 p.m.

New Paradigms in Treatment of Frontline and Relapsed T-cell Lymphoma


3:30 p.m.

Break & View Exhibits


4 p.m.   

Workshops (Concurrent sessions)


Perioperative Thrombocytopenia


Outpatient Conundrums in Hemostasis


Less Common Thromboses: 2020 Update


5 p.m.   

Adjourn

Monday, February 17, 2020

Topic: Updates in Oncology


7 a.m.   

Breakfast & View Exhibits


Moderator: Kathryn Bollin, MD  


8 a.m.   

Breakthroughs in the Understanding and Treatment of Brain Metastases


8:45 a.m.

Novel Approaches to the Patient with Prostate Cancer


9:30 a.m.

Break & View Exhibits


10 a.m.

Weighing the Evidence: How to Read Molecular Profiling Reports


10:45 a.m.

Updates in Endometrial Cancers


11:30 a.m.

Physician Wellness – Heal Thyself


12:15 p.m.

Lunch


Moderator: Munveer Bhangoo, MD         


1:15 p.m.

Novel Approaches to the Patient with Bladder Cancer


2 p.m.

Diet and the Microbiome in Melanoma: What to Tell Your Patient


2:45 p.m.

Emerging Options for Advanced Neuroendocrine Tumors


3:30 p.m.

Break & View Exhibits


3:45 p.m.

Sequencing Therapy in Metastatic Colorectal Cancer in the Era of “Sidedness” and TRIBE2


4:30 p.m.

Changing the Paradigm for Stage III Lung Cancer: Can We Replace Chemotherapy with Immunotherapy?


5:15 p.m.

Adjourn

Tuesday, February 18, 2020

Topic: Updates in Breast Cancer


7 a.m.

Breakfast


Moderator: Melissa Torrey, MD 


7:30 a.m.

Neoadjuvant Endocrine Therapy of Breast Cancer


8:15 a.m.

Optimal Approach to Residual Disease after Neoadjuvant Chemotherapy  


9 a.m.

Break


9:15 a.m.

Immunotherapy in Breast Cancer: The Future


10 a.m.

Recent Advances in Inflammatory Breast Cancer Management


10:45 a.m.

Surgery in Stage 4 (Oligometastatic) Disease


11:30 a.m.

Final Adjournment


Topics and speakers are subject to change